본문 바로가기

추천 검색어

실시간 인기 검색어

학술논문

한국형 우울장애 약물치료 알고리듬 2021 (II)

이용수 65

영문명
Korean Medication Algorithm Project for Depressive Disorder 2021 (II): The Subtypes of Depression
발행기관
대한신경정신의학회
저자명
박영민(Young-Min Park) 서정석(Jeong Seok Seo) 우영섭(Young Sup Woo) 박원명(Won-Myong Bahk) 김원(Won Kim) 정종현(Jong-
간행물 정보
『신경정신의학』제60권 제3호, 186~192쪽, 전체 7쪽
주제분류
의약학 > 정신과학
파일형태
PDF
발행일자
2021.08.31
4,000

구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.

1:1 문의
논문 표지

국문 초록

영문 초록

Objectives The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) was developed in 2002 and revised in 2006, 2012, 2017. In 2021, the fifth edition was published. This edition reflected new findings and the latest trends in the areas of pharmacological treatment. The aim of this study is to present strategies and treatment options according to the subtype of depression using data from the KMAP-DD-2021. Methods Ninety-seven psychiatrists with clinical experience in depressive disorder were selected. The questionnaires for KMAP-DD 2021 were sent to participants via mail. KMAP-DD 2021 consists of overall treatment strategies and treatment options under specific circumstances. Each treatment strategy or treatment option was evaluated with an overall score of nine and was divided into the three phases of recommendation that include primary, secondary, and tertiary. Results For persisting depressive disorder, antidepressant monotherapy including selectiveserotonin reuptake inhibitor (SSRI) (escitalopram, fluoxetine, sertraline, paroxetine), serotoninnorepinephrine reuptake inhibitor (SNRI) (desvenlafaxine, venlafaxine, duloxetine, milnacipran), vortioxetine, and mirtazapine, was recommended as first-line medications. For melancholia of major depressive disorder, SSRI, SNRI, vortioxetine, and mirtazapine also were recommended as first-line medications. For mixed features, SSRI, bupropion, mirtazapine, SNRI, except for duloxetine, and milnacipran were recommended as first-line medications. For anxious distress, SSRI, mirtazapine, and SNRI, except milnacipran, were recommended as first-line medications. Conclusion The preferences of antidepressants by experts differed according to the subtype of depression. These findings suggest that experts treat patients with a major depressive disorder after considering the subtype of depression involved.

목차

서 론
방 법
결 과
고 찰
결 론

키워드

해당간행물 수록 논문

참고문헌

교보eBook 첫 방문을 환영 합니다!

신규가입 혜택 지급이 완료 되었습니다.

바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!

교보e캐시 1,000원
TOP
인용하기
APA

박영민(Young-Min Park),서정석(Jeong Seok Seo),우영섭(Young Sup Woo),박원명(Won-Myong Bahk),김원(Won Kim),정종현(Jong-. (2021).한국형 우울장애 약물치료 알고리듬 2021 (II). 신경정신의학, 60 (3), 186-192

MLA

박영민(Young-Min Park),서정석(Jeong Seok Seo),우영섭(Young Sup Woo),박원명(Won-Myong Bahk),김원(Won Kim),정종현(Jong-. "한국형 우울장애 약물치료 알고리듬 2021 (II)." 신경정신의학, 60.3(2021): 186-192

결제완료
e캐시 원 결제 계속 하시겠습니까?
교보 e캐시 간편 결제